Application of carbon nanoparticle-labeled lymph nodes in laparoscopic curative resection for advancing rectal cancer
-
摘要:
目的 评价纳米炭在腹腔镜下进展期直肠癌根治术中的临床应用价值。 方法 选取2010年12月至2012年3月唐山市人民医院胃肠外科接受腹腔镜下直肠癌根治术治疗的80例患者，根据术中是否应用纳米炭分为试验组（40例）和对照组（40例），比较两组术中清扫淋巴结的总数，直径≤5 mm淋巴结数目及转移淋巴结数目，并观察有无药物不良反应。 结果 试验组注射纳米炭均未发生不良反应且术中黑染淋巴结清晰可辨；试验组患者清扫淋巴结总数[（25.5±8.78）枚vs.（16.05±4.84）枚]，直径≤5 mm淋巴结枚数[（22.6±8.25）枚vs.（13.65±4.62）枚]，转移淋巴结枚数[（3.13±4.14）枚vs.（1.35±2.06）枚]均显著高于对照组（P<0.05）；其中2例直肠癌患者术中发现肠系膜下动脉根部及髂内动脉旁有黑染淋巴结，相应扩大手术切除范围，术后病理证实淋巴结有肿瘤细胞转移。 结论 在腹腔镜下直肠癌根治术中，应用纳米炭对直肠癌淋巴结清扫有指导作用，方法安全、有效。 Abstract:Objective To evaluate the clinical value of activated carbon nanoparticles for guiding lymphadenectomy in advancing rectal cancer. Methods Eighty rectal cancer patients who underwent laparoscopic curative resection for rectal cancer were divided into two groups: control group (40 cases) and experiment group (40 cases). The experiment group received carbon nanoparticle-labeled lymph nodes in surgery. The number of lymph nodes, lymph nodes ≤5 mm in size, and positive lymph nodes, as well as the side effect of the procedure, were analyzed. Results No complications were observed in the experiment group. The experiment group showed significantly higher values (P<0.05) than the control group for average number of lymph nodes (25.5 ± 8.78 vs. 16.05 ± 4.84), lymph nodes ≤5mm in size (22.6±8.25 vs. 13.65±4.62), and positive lymph nodes (3.13±4.14 vs. 1.35±2.06). During operation, two dyed lymph nodes in two cases were found at the roof of the inferior mesenteric artery and along the side of the internal iliac artery. Dissection was extended for these patients and the dyed lymph nodes were confirmed to be positive. Conclusion Local injection of activated carbon nanoparticles around the tumor during surgical exploration was an effective, secure, and easy approach for guiding lymphadenectomy in rectal cancer patients. -
Key words:
- activated carbon nanoparticles /
- rectal neoplasm /
-
/ - laparoscope
-
表 1 两组患者临床资料比较 n（%）
Table 1. Clinical data of the two groups
表 2 术后两组患者检获淋巴结情况及手术时间比较 %
Table 2. Comparison of lymph node number after surgery and during surgery between the two groups of patients %
-
[1] Vather R, Sammour T, Kahokehr A, et al. Quantitative lymphnode evaluation as an independent marker of long-term prognosis in stageⅢrectal cancer[J]. ANZ J Surg, 2011, 81(12): 883-888. doi: 10.1111/j.1445-2197.2010.05595.x [2] Stocchi L, Fazio VW, Lavery I, et al. Individual surgeon, pathologist, and other factors affecting lymph node harvest in stage Ⅱ colon carcinoma: is a minimum of 12 examined lymph nodes suffi cient[J]? Ann Surg Oncol, 2011, 18(2): 405-412. doi: 10.1245/s10434-010-1308-5 [3] Hotta T, Takifuji K, Arii K, et al. Potentialpredictors of long-term survival after surgery forpatientswith stage Ⅳ colorectal cancer[J]. Anticancer Res, 2006, 26(2B): 1377-1383. [4] 李栢营, 王直, 姬生威, 等. 纳米碳示踪技术在胃癌根治术中的应用[J]. 现代肿瘤医学, 2012, 20(8): 1673-1674. doi: 10.3969/j.issn.1672-4992.2012.08.47 [5] Okamoto K, Sawai K, Minato H, et al. Number and anatomical extent of lymph node metastases in gastric cancer: analysis using intra-lymph node injection of activated carbon particles (CH40)[J]. Jpn J Clin Oncol, 1999, 29(2): 74-77. doi: 10.1093/jjco/29.2.74 [6] 颜博, 葛洁, 张刷, 等. 纳米碳在乳腺癌前哨淋巴结活检中的临床应用[J]. 中国肿瘤临床, 2011, 38(21): 1335-1337. doi: 10.3969/j.issn.1000-8179.2011.21.009 [7] 刘江文, 仝德峰, 牛建华, 等. 术中淋巴结示踪定位技术对进展期胃癌淋巴清扫指导作用的研究[J]. 实用肿瘤杂志, 2011, 26(4)369-371. https://www.cnki.com.cn/Article/CJFDTOTAL-SYZZ201104013.htm [8] Johnson PM, Porter GA, Ricciardi R, et al. Increasing negative lymph node count is independently associated with improved long-term survival in stage ⅢB and ⅢC colon cancer[J]. J Clin Oncol, 2006, 24(22): 3570-3575. doi: 10.1200/JCO.2006.06.8866 [9] Rivadulla-Serrano MI, Martinez-Ramos D, Armengol-Carrasco M, et al. Impact of the total number of harvested lymph nodes after colon cancer resections on survival in patients without involved lymph node[J]. Rev Esp Enferm Dig, 2010, 102(5): 296-301. [10] Noura S, Ohue M, Kano S, et al. Impact of metastatic lymph node ratio in node-positive colorectal cancer[J]. World J Gastrointest Surg, 2010, 2(3): 70-77. doi: 10.4240/wjgs.v2.i3.70 [11] Shao XL, Han HQ, He XL, et al. Impact of number of retrieved lymph nodes and lymph node ratio on the prognosis in patients with stage Ⅱ and Ⅲ colorectal cancer[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2011, 14(4): 249-253. [12] Watanabe A, Koyanagi T, Ohsawa H, et al. Systematic node dissection by VATS is not inferior to that through an open thoracotomy: a comparative clinicopathologic retrospective study[J]. Surgery, 2005, 138 (3): 510-517. doi: 10.1016/j.surg.2005.04.005 [13] Cai HK, He HF, Tian W, et al. Colorectal cancer lymph node staining by activated carbon nanoparticles suspension in vivo or methylene blue in vitro[J]. World J Gastroenterol, 2012, 18(42): 6148-6154. doi: 10.3748/wjg.v18.i42.6148 [14] Wang C, Zhou Z, Wang Z, et al. Patterns of neoplastic foci and lymph node micrometastasis within the mesorectum[J]. Langenbecks Arch Surg, 2005, 390(4): 312-318. doi: 10.1007/s00423-005-0562-7 [15] Wong JH, Bowles BJ, Bueno R, et al. Impact of the number of negative nodes on disease-free survival in colorectal cancer patients[J]. Dis Colon Rectum, 2002, 45 (10): 1341-1348. doi: 10.1007/s10350-004-6423-6 -
点击查看大图
表(2)
计量
- 文章访问数: 16
- HTML全文浏览量: 24
- PDF下载量: 1
- 被引次数: 0
下载:
